J&J’s 2017 full-year orthopedics sales fall flat, spine business line sales drop: 5 things to know

Spinal Tech

Johnson & Johnson released its fourth quarter and full-year financial results for 2017.

Here are five things to know:

 

1. Within the orthopedics segment, J&J reported $2.34 billion in fourth quarter sales, a 2 percent drop compared to fourth quarter sales in 2016.

 

2. J&J’s orthopedic segment also saw a dip in 2017 full-year sales from $9.33 billion in 2016 to $9.25 billion in 2017. This represents a 0.8 percent decline.

 

3. U.S. orthopedic sales dropped 2.3 percent in the fourth quarter, totaling $1.38 billion. International sales also decreased from $965 million in 2016 to $950 million in the fourth quarter of 2017.

 

4. Concerning the company's orthopedic medical devices, J&J's hip and trauma lines were the only two segments to experience year-over-year growth. The hip line grew 2.4 percent to $1.39 billion while the

trauma line grew 1.8 percent to $2.61 billion.

 

5. In the fourth quarter, J&J reported major declines to its spine business line. For the year-end, the company reported a 4 percent drop in sales to $3.72 billion.

 

Subscribe to the following topics: johnson & johnsonorthopedicsspinetraumahip and knee

Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


You can unsubscribe from these communications at any time. For more information, please review our Privacy Policy.
 

Articles We Think You'll Like

Featured Webinars